Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands; ORSI Academy, Melle, Belgium; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Eur Urol. 2021 Jan;79(1):124-132. doi: 10.1016/j.eururo.2020.10.031. Epub 2020 Nov 14.
The DROP-IN gamma probe was introduced to overcome the restricted manoeuvrability of traditional laparoscopic gamma probes. Through enhanced manoeuvrability and surgical autonomy, the DROP-IN promotes the implementation of radioguided surgery in the robotic setting.
To confirm the utility and safety profile of the DROP-IN gamma probe and to perform a comparison with the traditional laparoscopic gamma probe and fluorescence guidance.
DESIGN, SETTING, AND PARTICIPANTS: Twenty-five prostate cancer patients were scheduled for a robot-assisted sentinel lymph node (SN) procedure, extended pelvic lymph node dissection, and prostatectomy at a single European centre.
After intraprostatic injection of indocyanine green (ICG)-Tc-nanocolloid (n = 12) or Tc-nanocolloid + ICG (n = 13), SN locations were defined using preoperative imaging. Surgical excision of SNs was performed under image guidance using the DROP-IN gamma probe, the traditional laparoscopic gamma probe, and fluorescence imaging.
Intraoperative SN detection was assessed for the different modalities and related to anatomical locations. Patient follow-up was included (a median of 18 mo).
Overall, 47 SNs were pursued in vivo by the DROP-IN gamma probe, of which 100% were identified. No adverse events related to its use were observed. In vivo fluorescence imaging identified 91% of these SNs. The laparoscopic gamma probe identified only 76% of these SNs, where the detection inaccuracies appeared to be related to specific anatomical regions.
Owing to improved manoeuvrability, the DROP-IN probe yielded improved SN detection rates compared with the traditional gamma probe and fluorescence imaging. These findings underline that the DROP-IN technology provides a valuable tool for radioguided surgery in the robotic setting.
Radioguided robot-assisted surgery with the novel DROP-IN gamma probe is feasible and safe. It enables more efficient intraoperative identification of sentinel lymph nodes than can be achieved with a traditional laparoscopic gamma probe. The use of the DROP-IN probe in combination with fluorescence imaging allows for a complementary optical confirmation of node localisations.
DROP-IN 伽马探针的引入克服了传统腹腔镜伽马探针的操作受限问题。通过增强操作灵活性和手术自主性,DROP-IN 促进了机器人环境下放射性引导手术的实施。
确认 DROP-IN 伽马探针的实用性和安全性,并与传统腹腔镜伽马探针和荧光引导进行比较。
设计、地点和参与者:25 例前列腺癌患者在一家欧洲中心接受机器人辅助前哨淋巴结(SN)手术、扩大盆腔淋巴结清扫术和前列腺切除术。
在前列腺内注射吲哚菁绿(ICG)-Tc 纳米胶体(n=12)或 Tc 纳米胶体+ICG(n=13)后,使用术前成像定义 SN 位置。在 DROP-IN 伽马探针、传统腹腔镜伽马探针和荧光成像的引导下,通过手术切除 SN。
评估不同模式的术中 SN 检测,并与解剖位置相关联。包括患者随访(中位数为 18 个月)。
总体而言,DROP-IN 伽马探针在体内追踪到 47 个 SN,其中 100%被识别。未观察到与使用相关的不良事件。体内荧光成像识别了这些 SN 的 91%。传统腹腔镜伽马探针仅识别了这些 SN 的 76%,其中检测不准确似乎与特定的解剖区域有关。
由于操作灵活性提高,与传统伽马探针和荧光成像相比,DROP-IN 探针提高了 SN 检测率。这些发现强调了 DROP-IN 技术为机器人环境下放射性引导手术提供了一种有价值的工具。
新型 DROP-IN 伽马探针的放射性引导机器人辅助手术是可行和安全的。与传统腹腔镜伽马探针相比,它能更有效地在术中识别前哨淋巴结。DROP-IN 探针与荧光成像的结合使用允许对节点定位进行光学互补确认。